AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer
NCT04499118
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
HER2-negative Breast Cancer
Interventions
DRUG:
AT regimen
DRUG:
TP regimen
Sponsor
Sichuan Provincial People's Hospital